Literature DB >> 23412091

A nested case control study of plasma ICAM-1, E-selectin and TNF receptor 2 levels, and incident primary open-angle glaucoma.

Jae H Kang1, Janey L Wiggs, Louis R Pasquale.   

Abstract

PURPOSE: To evaluate prediagnostic markers of endothelial dysfunction and inflammatory processes in primary open-angle glaucoma (POAG).
METHODS: Blood samples were collected from 1989 to 1990 in the nurses' health study (women) and from 1993 to 1995 in the health professionals follow-up study (men), and medical-record confirmed incident poag cases were identified (women: 229 cases and 455 controls; men: 116 cases and 228 controls). Controls were matched on cohort, age, race, ethnicity, cancer status, and date of blood collection. Plasma concentrations of ICAM-1, E-selectin, and soluble TNF receptor 2 (sTNF-R2), a marker related to TNF-α, were measured with ELISA assays. Cohort-specific multivariable conditional logistic regression model results were meta-analyzed.
RESULTS: We observed no associations with ICAM-1 or E-selectin. for sTNF-R2, the mean (SD) plasma levels (pg/ml) in cases and controls were 2888 (997) and 2993 (913), respectively, in women; and 2622 (664) and 2569 (688), respectively, in men. pooled multivariable results showed no relation between sTNF-R2 levels and POAG. however, compared with the lowest tertile of sTNF-R2, the highest tertile showed a significant decreased risk of POAG in women (multivariable odds ratio [OR] = 0.58, 95% confidence interval [CI] = 0.360.93; P(trend) = 0.03) but not in men (P(trend) = 0.21; P for heterogeneity by sex = 0.03). also, among women, the inverse association with sTNF-R2 was stronger with normal-tension glaucoma (ntg; maximum intraocular pressure 21 mm Hg at diagnosis): highest versus lowest tertile comparison OR = 0.29 (95% CI = 0.12-0.71; Ptrend = 0.007).
CONCLUSIONS: In women, but not in men, higher sTNF-R2 levels at 6 to 8 years before diagnosis were inversely associated with POAG, but more strongly for NTG.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23412091      PMCID: PMC3626518          DOI: 10.1167/iovs.12-11191

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  76 in total

Review 1.  Cellular adhesion molecules and atherogenesis.

Authors:  D T Price; J Loscalzo
Journal:  Am J Med       Date:  1999-07       Impact factor: 4.965

2.  Copy number variations on chromosome 12q14 in patients with normal tension glaucoma.

Authors:  John H Fingert; Alan L Robin; Jennifer L Stone; Ben R Roos; Lea K Davis; Todd E Scheetz; Steve R Bennett; Thomas H Wassink; Young H Kwon; Wallace L M Alward; Robert F Mullins; Val C Sheffield; Edwin M Stone
Journal:  Hum Mol Genet       Date:  2011-03-29       Impact factor: 6.150

3.  [Effect of hormone replacement therapy on postmenopausal ocular function].

Authors:  C Sorrentino; P Affinito; F Mattace Raso; M Loffredo; P Merlino; A Loffredo; S Palomba; C Nappi
Journal:  Minerva Ginecol       Date:  1998 Jan-Feb

4.  Studies of factors involved in the production of low tension glaucoma.

Authors:  S M Drance; V P Sweeney; R W Morgan; F Feldman
Journal:  Arch Ophthalmol       Date:  1973-06

5.  TNF-alpha promoter polymorphisms and primary open-angle glaucoma.

Authors:  G Mossböck; M Weger; M Moray; W Renner; E M Haller-Schober; D Mattes; O Schmut; B Wegscheider; Y El-Shabrawi
Journal:  Eye (Lond)       Date:  2005-09-02       Impact factor: 3.775

6.  Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization.

Authors:  Zhihong Guo; Haiyang Jiang; Xiangru Xu; Wenzhen Duan; Mark P Mattson
Journal:  J Biol Chem       Date:  2007-11-09       Impact factor: 5.157

Review 7.  TNF-alpha signaling in glaucomatous neurodegeneration.

Authors:  Gülgün Tezel
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

8.  The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow.

Authors:  Ozgül Altintaş; Yusuf Caglar; Nurşen Yüksel; Ali Demirci; Levent Karabaş
Journal:  Ophthalmologica       Date:  2004 Mar-Apr       Impact factor: 3.250

9.  Serum cytokine alteration is associated with optic neuropathy in human primary open angle glaucoma.

Authors:  Ping Huang; Yue Qi; Yong-Sheng Xu; Jiahao Liu; Duanping Liao; Samuel Shao-Min Zhang; Chun Zhang
Journal:  J Glaucoma       Date:  2010 Jun-Jul       Impact factor: 2.503

10.  Antiapoptotic effects of leptin in human neuroblastoma cells.

Authors:  V C Russo; S Metaxas; K Kobayashi; M Harris; G A Werther
Journal:  Endocrinology       Date:  2004-05-27       Impact factor: 4.736

View more
  5 in total

Review 1.  Common and rare genetic risk factors for glaucoma.

Authors:  Ryan Wang; Janey L Wiggs
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-18       Impact factor: 6.915

2.  Sex hormone levels and risk of primary open-angle glaucoma in postmenopausal women.

Authors:  Jae Hee Kang; Bernard A Rosner; Janey L Wiggs; Louis R Pasquale
Journal:  Menopause       Date:  2018-10       Impact factor: 2.953

3.  A survey of preoperative blood tests in primary open-angle glaucoma patients versus cataract surgery patients.

Authors:  Laura P Cohen; Jessica Wong; Aliya Z Jiwani; Scott H Greenstein; Stacey C Brauner; Sherleen C Chen; Angela V Turalba; Teresa C Chen; Lucy Shen; Douglas J Rhee; Janey L Wiggs; Jae Hee Kang; Stephanie Loomis; Louis R Pasquale
Journal:  Digit J Ophthalmol       Date:  2014-06-30

4.  When Is a Control Not a Control? Reactive Microglia Occur Throughout the Control Contralateral Pathway of Retinal Ganglion Cell Projections in Experimental Glaucoma.

Authors:  James R Tribble; Eirini Kokkali; Amin Otmani; Flavia Plastino; Emma Lardner; Rupali Vohra; Miriam Kolko; Helder André; James E Morgan; Pete A Williams
Journal:  Transl Vis Sci Technol       Date:  2021-01-12       Impact factor: 3.283

5.  Involvement of Beclin‑1 in axonal protection by short‑term hyperglycemia against TNF‑induced optic nerve damage.

Authors:  Kana Sase; Yasushi Kitaoka; Chihiro Tsukahara; Hitoshi Takagi
Journal:  Mol Med Rep       Date:  2018-10-22       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.